![](/img/cover-not-exists.png)
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Oral LB20304 (Gemifloxacin) at Doses of 160mg or 320mg (Equivalent to 200mg or 400mg of the Mesylate Salt) Once Daily for 7 Days for the Treatment of Acute Exacerbations of Chronic Bronchitis (AECB) in Korean Adult Population
Kim, Young Whan, Shim, Young-Soo, Kim, Won Dong, Shim, Tae Sun, Kang, Hong Mo, Choi, ByoungWhui, Kim, Jae-Yeol, Kwon, O Jung, Kim, Hojoong, Kim, Ju Ock, Jung, Ki-Suck, Hyeon, In Gyou, Mo, Eun Kyung, LVolume:
55
Year:
2003
Journal:
Tuberculosis and Respiratory Diseases
DOI:
10.4046/trd.2003.55.1.69
File:
PDF, 939 KB
2003